Results for "The Role of Distributors in the U.S. Specialty Pharmaceuticals Value Chain"
FDA, Industry Experts Urge DSCSA Action at HDA’s 2023 Traceability Seminar
HDA convened more than 400 healthcare supply chain stakeholders, technology experts and regulatory officials for the association’s Traceability Seminar. This highly anticipated event provided a forum to discuss implementation challenges and strategies for Drug Supply Chain Security Act (DSCSA) compliance as the industry faced a November 27, 2023, deadline to establish a framework to trace pharmaceuticals across the supply chain.
HDA’s PCSC Honors Four Outstanding Security Leaders at Annual Seminar
The Healthcare Distribution Alliance (HDA) Pharmaceutical Cargo Security Coalition (PCSC) today recognized four security leaders at the annual PCSC Educational Seminar in Whippany, N.J. The PCSC Award is presented to supply chain security professionals who have exhibited remarkable standards of honesty and integrity while working tirelessly to protect and serve their communities.
HDA Statement on FDA’s Phased Exemption for Eligible Trading Partners from the DSCSA’s Final Implementation Requirements
HDA released a statement from President and CEO Chester “Chip” Davis, Jr., on the Food and Drug Administration’s (FDA) issuing of an exemption for eligible trading partners to comply with the final requirements of the Drug Supply Chain Security Act (DSCSA).
HDA Research Foundation Names Apotex and Anda Executives To Lead Board of Directors
The HDA Research Foundation announced Steve Giuli of Apotex Corp. as Chairman of its Board of Directors. Anthony Mihelich of Anda, Inc., was named Vice Chairman.
HDA Convenes Supply Chain Experts and Patient Advocates To Examine Drug Shortages Solutions
HDA recently hosted a LinkedIn Live discussion exploring how supply chain stakeholders are working together to tackle these challenges and advocate for solutions. The event featured perspectives from Laura Bray, Chief Change Maker and Founder of Angels for Change, and April Giles, Executive Director of the End Drug Shortages Alliance (EDSA). Chip Davis, HDA President and Chief Executive Officer, moderated the discussion, which also touched upon effects of recent hurricanes on the prescription supply and the newly announced Biden Cancer Moonshot pilot program to curb pediatric shortages.
Read three takeaways from the conversation.